- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01899222
Assessment of Prototype Hand-Held Fundus Camera
December 8, 2020 updated by: David Kleinman, University of Rochester
Assessment of handheld fundus images in comparison to conventional fundus camera images.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study is comparing a small handheld camera with a standard fundus camera for image quality
Study Type
Observational
Enrollment (Actual)
8
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Rochester, New York, United States, 14642
- University of Rochester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Ophthalmology clinic
Description
Inclusion criteria:
- Age > 18
- The ability to give informed consent and be willing to spend up to two hours in the eye clinic during the duration of the study.
- The subjects may have a normal retina and optic nerve, or subjects may have abnormalities of the posterior pole of the retina or the optic nerve.
Exclusion criteria:
- Medical or ophthalmic instability that would create a contraindication for minimally invasive ophthalmic diagnostic testing will exclude participation as a subject.
- Ophthalmic pathology felt by the principal investigator that would make retinal imaging with standard photographs difficult or not possible.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
fundus imaging
retinal photograph obtained at visit
|
diagnostic imaging with two types of retina camera
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of photographs that score a "3" or higher on the grading scale
Time Frame: 2-3 years
|
Photos will be evaluated by ophthalmologists and scored as follows:
|
2-3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 10, 2015
Primary Completion (Actual)
October 8, 2015
Study Completion (Actual)
October 8, 2015
Study Registration Dates
First Submitted
July 12, 2013
First Submitted That Met QC Criteria
July 12, 2013
First Posted (Estimate)
July 15, 2013
Study Record Updates
Last Update Posted (Actual)
December 9, 2020
Last Update Submitted That Met QC Criteria
December 8, 2020
Last Verified
December 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- HHFC 02
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Normal Subject Population
-
Procter and GambleCompletedNormal Healthy Subject PopulationUnited States
-
Fundación Pública Andaluza para la Investigación...Completed
-
Samuel FortinCompleted
-
Nervive, Inc.Centro Nacional de Investigacion en Imagenologia e Instrumentacion Medica...Completed
-
Cyberonics, Inc.CompletedECG Comparisons in Normal Healthy SubjectUnited States
-
Shanghai Vinnerna Biosciences Co., Ltd.Sponsor GmbHCompletedSubjects With Liver Function Injury | Normal Liver Function SubjectChina
-
Biomedical Development CorporationNational Center for Advancing Translational Sciences (NCATS); Michael Roman... and other collaboratorsUnknownNormal Elderly PopulationUnited States
-
HaEmek Medical Center, IsraelCompletedSchizophrenia | Normal PopulationIsrael
-
Hospices Civils de LyonNot yet recruitingNormal Subject | Patient With Pharmaco-resistant EpilepsyFrance
-
Prince of Songkla UniversityCompletedNormal Population | Glaucoma Patient | Glaucoma Suspect Patient | RNFL Thickness by Location | Macular Thickness by LocationThailand
Clinical Trials on Handheld fundus photography
-
Topcon CorporationCompleted
-
University of MichiganWashington University School of Medicine; University of California, BerkeleyEnrolling by invitationGlaucoma | Diabetes Mellitus | Diabetic Retinopathy | Age Related Macular Degeneration | Retinal Disease | ROP
-
Semmelweis UniversityCompletedCilioretinal ArteriesHungary
-
Digital Diagnostics, Inc.FortreaActive, not recruiting
-
Mayo ClinicEyenuk, Inc.; Malavika Bhaskaranand PhD; Kaushal SolankiCompletedAlzheimer Disease | Mild Cognitive Impairment | Vascular DementiaUnited States
-
Ophthalytics, Inc.Not yet recruiting
-
Pakistan Council of Scientific and Industrial ResearchAl-Ibrahim Eye HospitalRecruiting
-
Region StockholmRecruitingRetinal Hemorrhage, Bilateral | Retinal Hemorrhage, Left Eye | Retinal Hemorrhage, Right EyeSweden
-
Medical University of GrazCompletedAge-Related Macular Degeneration | Retinal Blood VesselsAustria